Susceptibility to innate immune activation in genetically mediated myocarditis
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Myocarditis is clinically characterized by chest pain, arrhythmias, and heart failure, and treatment is often supportive. Mutations in DSP , a gene encoding the desmosomal protein desmoplakin, have been increasingly implicated in myocarditis. To model DSP -associated myocarditis and assess the role of innate immunity, we generated engineered heart tissues (EHTs) using human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) from patients with heterozygous DSP truncating variants ( DSP tvs) and a gene-edited homozygous deletion cell line ( DSP –/– ). At baseline, DSP –/– EHTs displayed a transcriptomic signature of innate immune activation, which was mirrored by cytokine release. Importantly, DSP –/– EHTs were hypersensitive to Toll-like receptor (TLR) stimulation, demonstrating more contractile dysfunction compared with isogenic controls. Relative to DSP –/– EHTs, heterozygous DSP tv EHTs had less functional impairment. DSP tv EHTs displayed heightened sensitivity to TLR stimulation, and when subjected to strain, DSP tv EHTs developed functional deficits, indicating reduced contractile reserve compared with healthy controls. Colchicine or NF-κB inhibitors improved strain-induced force deficits in DSP tv EHTs. Genomic correction of DSP p.R1951X using adenine base editing reduced inflammatory biomarker release from EHTs. Thus, EHTs replicate electrical and contractile phenotypes seen in human myocarditis, implicating cytokine release as a key part of the myogenic susceptibility to inflammation. The heightened innate immune activation and sensitivity are targets for clinical intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of monumental importance, genetic correction of DSP p.R1951X was accompanied by a substantial reduction in NFκB mRNA expression, further suggesting that the mere presence of a desmosomal gene variant drives myocardial inflammation rather than being a consequence of infiltrating immune cells.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At baseline, DSP−/− EHTs exhibit a transcriptomic signature of innate immune activation, mirrored by elevated concentrations of multiple cytokines, including IL-1β, IL-6, IL-8, IFN-γ, IL-17, and IL-23, which were detected in the EHT cell culture media; thus, they are of cardiomyocyte origin rather than from immune cells [70].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DSP-linked ACM is strongly associated with a myocardial fibro-inflammatory phenotype and a higher frequency of episodic “hot phases,” typically manifesting in the left ventricle and frequently observed via LGE-MRI [52,70].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anti-inflammatory strategies, including colchicine, a broad anti-inflammatory agent, or NFκB inhibitors, effectively rescue these force deficits.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, heterozygous DSP-tv EHTs exhibited only minimal baseline contractile deficits, though they exhibited elevated innate immune activation relative to healthy controls, reflected by increased IL-1β secretion into cell culture media upon Toll-like receptor (TLR) stimulation via exogenous application of HMGB1.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
Concordet, J.-P., & Haeussler, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky354 · Cited by 2,655 · cited 1×
“DSP –/– cells were generated using gRNAs designed by CRISPOR (66), which targeted DSP exon 24 (Supplemental Table 7). gRNAs 190 and 202 were placed into the Cas9-expressing pSpCas9(BB)-2A-Puro (PX459) V2.”
MethodEasy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390 · cited 1×
“After 10 days, colonies were isolated and then screened by Sanger sequencing and TIDE analysis (67).”
MethodChemically defined generation of human cardiomyocytes
Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N. M., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2999 · Cited by 1,606 · cited 1×
“Cells were passaged once every 4–5 days at 80%–90% confluence by washing with 1× PBS and incubating with ReLeSR (STEMCELL Technologies, catalog 100-0483) for 3 minutes at 37°C. hiPSC-CMs were differentiated using small molecule modulation of the Wnt signaling pathway (64).”
MethodSelf-citationCardioimmunology: the immune system in cardiac homeostasis and disease
Swirski, F. K., & Nahrendorf, M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0065-8 · Cited by 849 · cited 1×
“Importantly, paracrine signaling from cardiomyocytes can amplify inflammation through local effects and by recruiting leukocytes to the myocardium, further intensifying mechanical defects (60, 61).”
BackgroundArrhythmogenic Right Ventricular Cardiomyopathy
Corrado, D., Link, M. S., & Calkins, H. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1509267 · Cited by 736
Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing
Atcha, H., Jairaman, A., Holt, J. R., Meli, V. S., Nagalla, R. R., Veerasubramanian, P. K., Brumm, K. T., Lim, H. E., Othy, S., Cahalan, M. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23482-5 · Cited by 644 · cited 1×
“In macrophages, PIEZO1 is required for inflammatory signaling, so it is possible that similar pathways are activated with desmosomal disruption in cardiomyocytes and skin (58, 59).”
BackgroundGiacomelli, E., Meraviglia, V., Campostrini, G., Cochrane, A., Cao, X., van Helden, R. W. J., Krotenberg Garcia, A., Mircea, M., Kostidis, S., Davis, R. P., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.05.004 · Cited by 622 · cited 1×
“Compared with hiPSC-CMs grown in monolayers in the dish, an advantage of bioengineered platforms like EHTs is the alignment of cardiomyocytes, which promotes the formation of intercellular junctions (37, 38).”
BackgroundEditR: A Method to Quantify Base Editing from Sanger Sequencing
Kluesner, M. G., Nedveck, D. A., Lahr, W. S., Garbe, J. R., Abrahante, J. E., Webber, B. R., & Moriarity, B. S. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0014 · Cited by 565 · cited 1×
“Editing efficiency was estimated using with EditR (69) to analyze chromatograms resulting from Sanger sequencing.”
Method
Research works printed but not linked: 1
- McNally E, et al. Arrhythmogenic Right Ventricular Cardiomyopathy Overview. In: Adam MP, et al., eds. GeneReviews. University of Washington; April 18, 2005. 20301310
Cited by
Advances in the study and treatment of genetic cardiomyopathies
Parikh, V. N., Day, S. M., Lakdawala, N. K., Adler, E., Olivotto, I., Seidman, C. E., & Ho, C. Y. (2025) · Cell · doi:10.1016/j.cell.2025.01.011 · Cited by 51
Simultaneous electromechanical monitoring in engineered heart tissues using a mesoscale framework
Fullenkamp, D. E., Maeng, W., Oh, S., Luan, H., Kim, K. S., Chychula, I. A., Kim, J., Yoo, J., Holgren, C. W., Demonbreun, A. R., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado7089 · Cited by 44
Self-citationGasperetti, A., Muller, S. A., Peretto, G., Asatryan, B., Protonotarios, A., Laredo, M., Tarlet, P.-Y., Syrris, P., Carrick, R. T., Murray, B., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.073919 · Cited by 36
Desmoplakin Cardiomyopathy: Role of Inflammation and Potential Role of Disease-Modifying Therapies
Gasperetti, A., Carrick, R. T., Muller, S. A., Murray, B. A., Adamo, L., Bauce, B., McNally, E. M., & Helms, A. S. (2025) · Current Cardiology Reports · doi:10.1007/s11886-024-02183-7 · Cited by 13
“In both studies, iPSC-CMs were used to generate heart tissues, and when these tissues were exposed to excess tension, dysfunction of the tissues developed [21, 33].”
Self-citationMaihemuti, N., Shi, Y., Zhang, K., Jiang, X., Chu, J., Xu, Y., Xu, Z., & Wang, K. (2025) · MedComm · doi:10.1002/mco2.70308 · Cited by 12
“Desmosome knockout cell lines exhibit heightened sensitivity to TLRs–NF-κ B signaling, and this response has shown to be remedied by NF-κ B inhibitors, establishing desmosomes as novel regulators of TLR signaling [241].”
Peretto, G., Villatore, A., & Cooper, L. T. (2026) · Immunological Reviews · doi:10.1111/imr.70105 · Cited by 10
Smith, E. D., Jin, K., Ferguson, B., Tsan, Y.-C., DePalma, S. J., Meisner, J. K., Renberg, A., Bedi, K. C., Friedline, S., Margulies, K. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.01.657304 · Cited by 9
Ammirati, E., Cartella, I., Ciabatti, M., Colombo, G., Masetti, M., Pieroni, M., Gallone, G., Peretto, G., Potena, L., Scacciavillani, R., et al. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvag058 · Cited by 5
“…engineered heart tissues with human-induced pluripotent stem cell-derived cardiomyocytes from patients with heterozygous DSP showed that colchicine improved the strain-induced force deficits, 30 providing a rationale for testing colchicine also in patients with Infl-CMP and a genetic background.”
InfluentialStangner, K., Dervishi, O., Kuhnert, J., Wendt, C., Pathak, S., Shoykhet, M., Olivares‐Florez, S., Moztarzadeh, S., Opsteen, J., Wohlfarth, N. L. C. S., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04755-y · Cited by 4
“…hiPSCs, which can be differentiated into CMs, offering a robust in vitro model for studying ACM (Chelko, Asimaki et al. [8], Padron-Barthe, Vil-lalba-Orero et al. [34], Kim, Trembley et al. [28], Maione, Meraviglia et al. [29], Seibertz, Rubio et al. [45], Selgrade, Fullenkamp et al. [46]).”
Exploring the Genetic Architecture of Myocarditis and Inherited Cardiomyopathies
Kundur, S. P., Malik, A. H., Mizori, R., & Sivalokanathan, S. (2026) · Cardiogenetics · doi:10.3390/cardiogenetics16010004 · Cited by 2
RhoGEF Ect2 supports RhoA activity at cell–cell junctions through desmoplakin
Zarkoob, H., Kam, C. Y., Koetsier, J. L., McCarthy, E. F., Jaiganesh, A., Kelsell, D. P., Sheikh, F., Godsel, L. M., & Green, K. J. (2026) · Life Science Alliance · doi:10.26508/lsa.202503454 · Cited by 2
“Inherited mutations in DSP have been found to be a frequent causative factor underlying myocardial diseases including arrhythmogenic cardiomyopathy (AC), dilated cardiomyopathy, and myocarditis (27, 28, 29).”
Self-citationIs it Time to Incorporate Genomic Data in the Routine Evaluation of Cardiac Sarcoidosis?
Ezzeddine, F. M., Tseng, A. S., Bois, M. C., & Cooper, L. T. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101745 · Cited by 2
A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease
Ariyaratne, G. H. D. N., Villatore, A., Peretto, G., & Chelko, S. P. (2026) · Cells · doi:10.3390/cells15100868 · Cited by 2
“DSP -linked ACM is strongly associated with a myocardial fibro-inflammatory phenotype and a higher frequency of episodic “hot phases,” typically manifesting in the left ventricle and frequently observed via LGE-MRI [52,70].”
InfluentialDesmoplakin cardiomyopathy: recent updates in natural history and management
Hoffman‐Andrews, L., Anderson, O. G., & OWENS, A. T. (2025) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001240 · Cited by 1
Han, D. D., Brooks, A. C., Baker, C. D., Dirkx, R. A., Mickelsen, D. M., Fisler, B., Phadke, K., Ashton, J. M., Delmar, M., & Small, E. M. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013966 · Cited by 1
Nikitina, E. V., Kofeynikova, O. А., Zlotina, A. M., Pervunina, T. M., Vasichkina, E. S., Головкин, А. С., Kalinina, O., & Kostareva, A. A. (2025) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v14.i4.108329 · Cited by 2
Desmoplakin Loss Leads to PKC- and Src-Mediated Contractile Dysfunction in Cardiomyocytes
Gokhan, I., McKay, M., Li, X., Zanetti, M., Granger, J. M., Sendek, J. M., Pagan, A. J. M., Campbell, K. S., Akar, F. G., & Campbell, S. G. (2026) · Circulation Research · doi:10.1161/circresaha.125.327676 · Cited by 1
Characteristics and pharmacological responsiveness in hiPSC models of inherited cardiomyopathy
Gerritse, M., van Ham, W. B., Denning, C. N., van Veen, T. A. B., & Maas, R. G. C. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108845 · Cited by 1
A Multiple Hit Model for Genetic Susceptibility to Cardiomyopathy
McNally, E. M. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.10.013 · Cited by 2
Self-citationGokhan, I., Li, X., Sendek, J. M., Pagan, A. J. M., Akar, F. G., & Campbell, S. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.15.654389 · Cited by 1
Zarkoob, H., Kam, C. Y., Koetsier, J. L., Jaiganesh, A., McCarthy, E. F., Kelsell, D. P., Sheikh, F., Godsel, L. M., & Green, K. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.21.655405
Self-citationWeber, Z., Monroe, T. O., Holgren, C. W., Mitchell, R. M., Zhang, L., Thornburg, A. G., Salamone, I. M., Puckelwartz, M. J., Liu, X., McNally, E. M., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7696371/v1
Self-citationA combined genomic arrhythmia propensity score delineates cumulative risk
Monroe, T. O., Puckelwartz, M. J., Pesce, L. L., Kearns, S. D., Page, P., Ibrahim, N., Weber, Z., Ugwor, E. I., Nóbrega, M. A., Kannankeril, P. J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102455 · Cited by 1
Self-citationCheng, H., Wang, J., & Ting, W. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2583276 · Cited by 1
Cardiac innate lymphoid cells: the role of innate immune regulation in cardiovascular diseases
Huang, Q., Jin, J., Dong, Z., & Tian, Y. (2025) · Clinical & Experimental Immunology · doi:10.1093/cei/uxaf080 · Cited by 1
Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
Keil, R., Misiak, D., Hüttelmaier, S., Tellkamp, F., Krüger, M., & Hatzfeld, M. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01462-3
“All mouse procedures were approved by the local authorities (Landesverwaltungsamt Saxony-Anhalt permit number: 2-1482) and performed in accordance with institutional policies.”
Broadbent, S. D., Bhagwan, J. R., Olusoga, T., & Barnes, A. A. (2026) · Biochemical Society Transactions · doi:10.1042/bst20253028 · Cited by 1
Liu, C., Wen, W., Qu, M., Jin, Z., Xu, J., Lu, X., & Zhang, Z. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1750721
Engineered Heart Tissues Facilitate Noncoding Variant Studies in Cardiomyopathy
Weber, Z., Monroe, T. O., Holgren, C. W., Mitchell, R. M., Zhang, L., Thornburg, A. G., Salamone, I. M., Chychula, I. A., Karthik, F., Fullenkamp, D. E., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327506
Self-citationGenetic Determinants of Autoimmune Myocarditis: From Candidate Genes to GWAS Insights
Pirzadah, H., Ibrahim, Z., Pirzadah, Y., & Yusuf, N. (2026) · Genes · doi:10.3390/genes17070834
“…DSP − / − cell lines exhibit baseline immune activation and cytokine release (through innate immune activation and NF-κ B signaling) and exhibit heightened sensitivity to Toll-like receptor (TLR) stimulation, resulting in more significant contractile dysfunction compared to isogenic controls [42].”
Metadata
- Authors
- Selgrade, D. F., Fullenkamp, D. E., Chychula, I. A., Li, B., Dellefave-Castillo, L., Dubash, A. D., Ohiri, J., Monroe, T. O., Blancard, M., Tomar, G., Holgren, C., Burridge, P. W., George, A. L., Demonbreun, A. R., Puckelwartz, M. J., George, S. A., Efimov, I. R., Green, K. J., & McNally, E. M.
- Affiliations
- Center for Genetic Medicine and
- Northwestern University (US)
- Furman University (US)
- Department of Pharmacology,
- Corresponding author
- McNally, Elizabeth M.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2024-05-16
- Volume
- 134
- Issue
- 13
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC11213508
- OpenAlex
- W4398143267
- Cited by
- 30
- References
- 72
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 2
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- NIH (NIH HL128075 (EMM),NIH HL167813,NIH HL162454 (DFS),NIH HL163392 (DEF),NIH AR43380 (KJG),NIH HL134633 (DFS),Leducq TransAtlantic Foundation (DEF,EMM),International Institute for Nanotechnology Northwestern University (DFS),Chicago Biomedical Consortium PDR)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- desmoplakin, desmosomal proteins, innate immune activation, engineered heart tissue, hiPSC-derived cardiomyocytes, cytokine production, contractile dysfunction, NF-κB inhibition, colchicine, adenine base editing, gene correction, truncating mutations
- MeSH terms
- Female, Humans, Immunity, Innate, Male, Myocarditis, Genetic Predisposition to Disease, Myocytes, Cardiac, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.